In the US, Dipyridamole (dipyridamole systemic) is a member of the following drug classes: cardiac stressing agents, platelet aggregation inhibitors and is used to treat Prosthetic Heart Valves - Thrombosis Prophylaxis and Radionuclide Myocardial Perfusion Study.
- DIPYRIDAMOLE 100MG TABLETS (Leaflet)
- DIPYRIDAMOLE 100MG/5ML ORAL SUSPENSION (Leaflet)
- DIPYRIDAMOLE 200MG/5ML ORAL SUSPENSION (Leaflet)
- DIPYRIDAMOLE 25MG TABLETS (Leaflet)
- DIPYRIDAMOLE 50 MG/5 ML ORAL SUSPENSION (Leaflet)
- DIPYRIDAMOLE 50MG/5ML ORAL SUSPENSION (Leaflet)
- DIPYRIDAMOLE BP 100MG (Leaflet)
- DIPYRIDAMOLE BP 25MG (Leaflet)
- DIPYRIDAMOLE TABLETS 100MG (Leaflet)
- DIPYRIDAMOLE TABLETS 25MG (Leaflet)
- DIPYRIDAMOLE TABLETS BP 100MG (Leaflet)
- DIPYRIDAMOLE TABLETS BP 25MG (Leaflet)
Ingredient matches for Dipyridamole
Dipyridamole (BAN, DCF, JAN, USAN) is known as Dipyridamole in the US.
Isosorbide Mononitrate is reported as an ingredient of Dipyridamole in the following countries:
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|JAN||Japanese Accepted Name|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.